At AstraZeneca, we’re committed to diving deep into the root cause of heart failure to determine the changes we need to make in ways we treat this disease, transform care and ultimately improve outcomes.
马丁·考伊, Interim Senior Vice President Late-Stage 发展, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca
澳门葡京赌博游戏有
projects in our pipeline